Q4 EPS SEK 3.0, 10% above ARCe/Cons. Reported ROE 13.0%NII -4% q/q and 1% below estimates, while adj. revenues look fairly in line.... But costs 6% below (5% adj. for Oktogonen reversal) leads to a solid PTP beatProposes SEK 8.0 ordinary DPS + 9.5 XO for SEK 17.5 total, 12.2% yieldOverall positive report despite NII miss, expect share to outperform today
